Literature DB >> 19716622

Cancer stem cell: implications in cancer biology and therapy with special reference to lung cancer.

Hitoshi Kitamura1, Koji Okudela, Takuya Yazawa, Hanako Sato, Hiroaki Shimoyamada.   

Abstract

The cancer stem cell (CSC) theory is currently central to the field of cancer research, because it is not only a matter of academic interest but also crucial in cancer therapy. CSCs share a variety of biological properties with normal somatic stem cells in terms of self-renewal, the propagation of differentiated progeny, the expression of specific cell markers and stem cell genes, and the utilization of common signaling pathways and the stem cell niche. However, CSCs differ from normal stem cells in their tumorigenic activity. Thus, CSCs are also termed cancer initiating cells. In this paper, we briefly review hitherto described study results and refer to some excellent review articles to understand the basic properties of CSCs. In addition, we focus upon CSCs of lung cancers, since lung cancer is still increasing in incidence worldwide and remains the leading cause of cancer deaths. Understanding the properties of, and exploring cell markers and signaling pathways specific to, CSCs of lung cancers, will lead to progress in therapy, intervention, and improvement of the prognosis of patients with lung cancer. In the near future, the evaluation of CSCs may be a routine part of practical diagnostic pathology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19716622     DOI: 10.1016/j.lungcan.2009.07.019

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  34 in total

Review 1.  Targeting CSCs in tumor microenvironment: the potential role of ROS-associated miRNAs in tumor aggressiveness.

Authors:  Bin Bao; Asfar S Azmi; Yiwei Li; Aamir Ahmad; Shadan Ali; Sanjeev Banerjee; Dejuan Kong; Fazlul H Sarkar
Journal:  Curr Stem Cell Res Ther       Date:  2014-01       Impact factor: 3.828

Review 2.  Ovarian cancer stem cells: Can targeted therapy lead to improved progression-free survival?

Authors:  Christen L Walters Haygood; Rebecca C Arend; J Michael Straughn; Donald J Buchsbaum
Journal:  World J Stem Cells       Date:  2014-09-26       Impact factor: 5.326

Review 3.  Molecular biology of lung cancer: clinical implications.

Authors:  Jill E Larsen; John D Minna
Journal:  Clin Chest Med       Date:  2011-10-07       Impact factor: 2.878

Review 4.  [Preneoplastic lesions of pulmonary carcinoma].

Authors:  L Bubendorf
Journal:  Pathologe       Date:  2011-11       Impact factor: 1.011

5.  Epithelial-mesenchymal transition in patients of pulmonary adenocarcinoma: correlation with cancer stem cell markers and prognosis.

Authors:  Woo Jung Sung; Ki-Sung Park; Sang Gyu Kwak; Dae-Sung Hyun; Jae Seok Jang; Kwan-Kyu Park
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

6.  The inflammatory tumor microenvironment, epithelial mesenchymal transition and lung carcinogenesis.

Authors:  Eileen L Heinrich; Tonya C Walser; Kostyantyn Krysan; Elvira L Liclican; Jeanette L Grant; Nicole L Rodriguez; Steven M Dubinett
Journal:  Cancer Microenviron       Date:  2011-09-16

7.  Genetic Variation in CD166 Gene and Its Association with Bladder Cancer Risk in North Indian Population.

Authors:  Archana Verma; Rakesh Kapoor; Rama Devi Mittal
Journal:  Indian J Clin Biochem       Date:  2016-08-26

8.  Prognostic value of CD133 expression in stage I lung adenocarcinomas.

Authors:  Tetsukan Woo; Koji Okudela; Hideaki Mitsui; Takuya Yazawa; Nobuo Ogawa; Michihiko Tajiri; Taketsugu Yamamoto; Yasushi Rino; Hitoshi Kitamura; Munetaka Masuda
Journal:  Int J Clin Exp Pathol       Date:  2010-12-04

Review 9.  Targeted therapies for lung cancer: clinical experience and novel agents.

Authors:  Jill E Larsen; Tina Cascone; David E Gerber; John V Heymach; John D Minna
Journal:  Cancer J       Date:  2011 Nov-Dec       Impact factor: 3.360

10.  Comparison of leucine-rich repeat-containing G protein-coupled receptor 5 expression in different cancer and normal cell lines.

Authors:  Reza Alizadeh-Navaei; Alireza Rafiei; Saeid Abedian-Kenari; Hossein Asgarian-Omran; Reza Valadan; Akbar Hedayatizadeh-Omran
Journal:  Biomed Rep       Date:  2016-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.